▶ 調査レポート

ネットワークポイントオブケアグルコース検査装置のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Network Point-of-Care Glucose Testing Device Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ネットワークポイントオブケアグルコース検査装置のグローバル市場インサイト・予測(~2028年) / Global Network Point-of-Care Glucose Testing Device Market Insights, Forecast to 2028 / QY2207E09876資料のイメージです。• レポートコード:QY2207E09876
• 出版社/出版日:QYResearch / 2022年7月
• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のネットワークポイントオブケアグルコース検査装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にネットワークポイントオブケアグルコース検査装置の世界市場のxxx%を占める「0.5uL / 0.6uL」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のネットワークポイントオブケアグルコース検査装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのネットワークポイントオブケアグルコース検査装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのネットワークポイントオブケアグルコース検査装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ネットワークポイントオブケアグルコース検査装置のグローバル主要メーカーには、Roche Holding AG、Ascensia Diabetes Care Holdings AG、Nova Biomedical、LifeScan, Inc.、Danaher Corporation、Prodigy Diabetes Care、Johnson & Johnson、Nipro、ACON Laboratories, Inc.、Trividia Health, Inc.、Panasonic Healthcare Holdings、EKF Diagnostics、Omron、B. Braun、77 Elektronika、AgaMatrix、Terumoなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ネットワークポイントオブケアグルコース検査装置市場は、種類と用途によって区分されます。世界のネットワークポイントオブケアグルコース検査装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
0.5uL / 0.6uL、1uL、1.5uL、その他

【用途別セグメント】
病院、クリニック、家庭

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ネットワークポイントオブケアグルコース検査装置製品概要
- 種類別市場(0.5uL / 0.6uL、1uL、1.5uL、その他)
- 用途別市場(病院、クリニック、家庭)
- 調査の目的
・エグゼクティブサマリー
- 世界のネットワークポイントオブケアグルコース検査装置販売量予測2017-2028
- 世界のネットワークポイントオブケアグルコース検査装置売上予測2017-2028
- ネットワークポイントオブケアグルコース検査装置の地域別販売量
- ネットワークポイントオブケアグルコース検査装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ネットワークポイントオブケアグルコース検査装置販売量
- 主要メーカー別ネットワークポイントオブケアグルコース検査装置売上
- 主要メーカー別ネットワークポイントオブケアグルコース検査装置価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(0.5uL / 0.6uL、1uL、1.5uL、その他)
- ネットワークポイントオブケアグルコース検査装置の種類別販売量
- ネットワークポイントオブケアグルコース検査装置の種類別売上
- ネットワークポイントオブケアグルコース検査装置の種類別価格
・用途別市場規模(病院、クリニック、家庭)
- ネットワークポイントオブケアグルコース検査装置の用途別販売量
- ネットワークポイントオブケアグルコース検査装置の用途別売上
- ネットワークポイントオブケアグルコース検査装置の用途別価格
・北米市場
- 北米のネットワークポイントオブケアグルコース検査装置市場規模(種類別、用途別)
- 主要国別のネットワークポイントオブケアグルコース検査装置市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのネットワークポイントオブケアグルコース検査装置市場規模(種類別、用途別)
- 主要国別のネットワークポイントオブケアグルコース検査装置市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のネットワークポイントオブケアグルコース検査装置市場規模(種類別、用途別)
- 主要国別のネットワークポイントオブケアグルコース検査装置市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のネットワークポイントオブケアグルコース検査装置市場規模(種類別、用途別)
- 主要国別のネットワークポイントオブケアグルコース検査装置市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのネットワークポイントオブケアグルコース検査装置市場規模(種類別、用途別)
- 主要国別のネットワークポイントオブケアグルコース検査装置市場規模(トルコ、サウジアラビア)
・企業情報
Roche Holding AG、Ascensia Diabetes Care Holdings AG、Nova Biomedical、LifeScan, Inc.、Danaher Corporation、Prodigy Diabetes Care、Johnson & Johnson、Nipro、ACON Laboratories, Inc.、Trividia Health, Inc.、Panasonic Healthcare Holdings、EKF Diagnostics、Omron、B. Braun、77 Elektronika、AgaMatrix、Terumo
・産業チェーン及び販売チャネル分析
- ネットワークポイントオブケアグルコース検査装置の産業チェーン分析
- ネットワークポイントオブケアグルコース検査装置の原材料
- ネットワークポイントオブケアグルコース検査装置の生産プロセス
- ネットワークポイントオブケアグルコース検査装置の販売及びマーケティング
- ネットワークポイントオブケアグルコース検査装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ネットワークポイントオブケアグルコース検査装置の産業動向
- ネットワークポイントオブケアグルコース検査装置のマーケットドライバー
- ネットワークポイントオブケアグルコース検査装置の課題
- ネットワークポイントオブケアグルコース検査装置の阻害要因
・主な調査結果

Market Analysis and Insights: Global Network Point-of-Care Glucose Testing Device Market
Due to the COVID-19 pandemic, the global Network Point-of-Care Glucose Testing Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 0.5uL/0.6uL accounting for % of the Network Point-of-Care Glucose Testing Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Network Point-of-Care Glucose Testing Device market size is valued at US$ million in 2021, while the US and Europe Network Point-of-Care Glucose Testing Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Network Point-of-Care Glucose Testing Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Network Point-of-Care Glucose Testing Device include Roche Holding AG, Ascensia Diabetes Care Holdings AG, Nova Biomedical, LifeScan, Inc., Danaher Corporation, Prodigy Diabetes Care, Johnson & Johnson, Nipro and ACON Laboratories, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Network Point-of-Care Glucose Testing Device Scope and Segment
Network Point-of-Care Glucose Testing Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Network Point-of-Care Glucose Testing Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
0.5uL/0.6uL
1uL
1.5uL
Others
Segment by Application
Hospital
Clinic
Household
By Company
Roche Holding AG
Ascensia Diabetes Care Holdings AG
Nova Biomedical
LifeScan, Inc.
Danaher Corporation
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Network Point-of-Care Glucose Testing Device Product Introduction
1.2 Market by Type
1.2.1 Global Network Point-of-Care Glucose Testing Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.5uL/0.6uL
1.2.3 1uL
1.2.4 1.5uL
1.2.5 Others
1.3 Market by Application
1.3.1 Global Network Point-of-Care Glucose Testing Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Network Point-of-Care Glucose Testing Device Sales Estimates and Forecasts 2017-2028
2.2 Global Network Point-of-Care Glucose Testing Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Network Point-of-Care Glucose Testing Device Sales by Region
2.4.1 Global Network Point-of-Care Glucose Testing Device Sales by Region (2017-2022)
2.4.2 Global Sales Network Point-of-Care Glucose Testing Device by Region (2023-2028)
2.5 Global Network Point-of-Care Glucose Testing Device Revenue by Region
2.5.1 Global Network Point-of-Care Glucose Testing Device Revenue by Region (2017-2022)
2.5.2 Global Network Point-of-Care Glucose Testing Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Network Point-of-Care Glucose Testing Device Sales by Manufacturers
3.1.1 Global Top Network Point-of-Care Glucose Testing Device Manufacturers by Sales (2017-2022)
3.1.2 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Network Point-of-Care Glucose Testing Device in 2021
3.2 Global Network Point-of-Care Glucose Testing Device Revenue by Manufacturers
3.2.1 Global Network Point-of-Care Glucose Testing Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Network Point-of-Care Glucose Testing Device Revenue in 2021
3.3 Global Network Point-of-Care Glucose Testing Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Network Point-of-Care Glucose Testing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Network Point-of-Care Glucose Testing Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Network Point-of-Care Glucose Testing Device Sales by Type
4.1.1 Global Network Point-of-Care Glucose Testing Device Historical Sales by Type (2017-2022)
4.1.2 Global Network Point-of-Care Glucose Testing Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2017-2028)
4.2 Global Network Point-of-Care Glucose Testing Device Revenue by Type
4.2.1 Global Network Point-of-Care Glucose Testing Device Historical Revenue by Type (2017-2022)
4.2.2 Global Network Point-of-Care Glucose Testing Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2017-2028)
4.3 Global Network Point-of-Care Glucose Testing Device Price by Type
4.3.1 Global Network Point-of-Care Glucose Testing Device Price by Type (2017-2022)
4.3.2 Global Network Point-of-Care Glucose Testing Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Network Point-of-Care Glucose Testing Device Sales by Application
5.1.1 Global Network Point-of-Care Glucose Testing Device Historical Sales by Application (2017-2022)
5.1.2 Global Network Point-of-Care Glucose Testing Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2017-2028)
5.2 Global Network Point-of-Care Glucose Testing Device Revenue by Application
5.2.1 Global Network Point-of-Care Glucose Testing Device Historical Revenue by Application (2017-2022)
5.2.2 Global Network Point-of-Care Glucose Testing Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2017-2028)
5.3 Global Network Point-of-Care Glucose Testing Device Price by Application
5.3.1 Global Network Point-of-Care Glucose Testing Device Price by Application (2017-2022)
5.3.2 Global Network Point-of-Care Glucose Testing Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Network Point-of-Care Glucose Testing Device Market Size by Type
6.1.1 North America Network Point-of-Care Glucose Testing Device Sales by Type (2017-2028)
6.1.2 North America Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2028)
6.2 North America Network Point-of-Care Glucose Testing Device Market Size by Application
6.2.1 North America Network Point-of-Care Glucose Testing Device Sales by Application (2017-2028)
6.2.2 North America Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2028)
6.3 North America Network Point-of-Care Glucose Testing Device Market Size by Country
6.3.1 North America Network Point-of-Care Glucose Testing Device Sales by Country (2017-2028)
6.3.2 North America Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Network Point-of-Care Glucose Testing Device Market Size by Type
7.1.1 Europe Network Point-of-Care Glucose Testing Device Sales by Type (2017-2028)
7.1.2 Europe Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2028)
7.2 Europe Network Point-of-Care Glucose Testing Device Market Size by Application
7.2.1 Europe Network Point-of-Care Glucose Testing Device Sales by Application (2017-2028)
7.2.2 Europe Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2028)
7.3 Europe Network Point-of-Care Glucose Testing Device Market Size by Country
7.3.1 Europe Network Point-of-Care Glucose Testing Device Sales by Country (2017-2028)
7.3.2 Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Network Point-of-Care Glucose Testing Device Market Size by Type
8.1.1 Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2028)
8.2 Asia Pacific Network Point-of-Care Glucose Testing Device Market Size by Application
8.2.1 Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2028)
8.3 Asia Pacific Network Point-of-Care Glucose Testing Device Market Size by Region
8.3.1 Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Network Point-of-Care Glucose Testing Device Market Size by Type
9.1.1 Latin America Network Point-of-Care Glucose Testing Device Sales by Type (2017-2028)
9.1.2 Latin America Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2028)
9.2 Latin America Network Point-of-Care Glucose Testing Device Market Size by Application
9.2.1 Latin America Network Point-of-Care Glucose Testing Device Sales by Application (2017-2028)
9.2.2 Latin America Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2028)
9.3 Latin America Network Point-of-Care Glucose Testing Device Market Size by Country
9.3.1 Latin America Network Point-of-Care Glucose Testing Device Sales by Country (2017-2028)
9.3.2 Latin America Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Network Point-of-Care Glucose Testing Device Market Size by Type
10.1.1 Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Network Point-of-Care Glucose Testing Device Market Size by Application
10.2.1 Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Network Point-of-Care Glucose Testing Device Market Size by Country
10.3.1 Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche Holding AG
11.1.1 Roche Holding AG Corporation Information
11.1.2 Roche Holding AG Overview
11.1.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Holding AG Recent Developments
11.2 Ascensia Diabetes Care Holdings AG
11.2.1 Ascensia Diabetes Care Holdings AG Corporation Information
11.2.2 Ascensia Diabetes Care Holdings AG Overview
11.2.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ascensia Diabetes Care Holdings AG Recent Developments
11.3 Nova Biomedical
11.3.1 Nova Biomedical Corporation Information
11.3.2 Nova Biomedical Overview
11.3.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nova Biomedical Recent Developments
11.4 LifeScan, Inc.
11.4.1 LifeScan, Inc. Corporation Information
11.4.2 LifeScan, Inc. Overview
11.4.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LifeScan, Inc. Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Corporation Information
11.5.2 Danaher Corporation Overview
11.5.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Danaher Corporation Recent Developments
11.6 Prodigy Diabetes Care
11.6.1 Prodigy Diabetes Care Corporation Information
11.6.2 Prodigy Diabetes Care Overview
11.6.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Prodigy Diabetes Care Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Nipro
11.8.1 Nipro Corporation Information
11.8.2 Nipro Overview
11.8.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nipro Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nipro Recent Developments
11.9 ACON Laboratories, Inc.
11.9.1 ACON Laboratories, Inc. Corporation Information
11.9.2 ACON Laboratories, Inc. Overview
11.9.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ACON Laboratories, Inc. Recent Developments
11.10 Trividia Health, Inc.
11.10.1 Trividia Health, Inc. Corporation Information
11.10.2 Trividia Health, Inc. Overview
11.10.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Trividia Health, Inc. Recent Developments
11.11 Panasonic Healthcare Holdings
11.11.1 Panasonic Healthcare Holdings Corporation Information
11.11.2 Panasonic Healthcare Holdings Overview
11.11.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Panasonic Healthcare Holdings Recent Developments
11.12 EKF Diagnostics
11.12.1 EKF Diagnostics Corporation Information
11.12.2 EKF Diagnostics Overview
11.12.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EKF Diagnostics Recent Developments
11.13 Omron
11.13.1 Omron Corporation Information
11.13.2 Omron Overview
11.13.3 Omron Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Omron Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Omron Recent Developments
11.14 B. Braun
11.14.1 B. Braun Corporation Information
11.14.2 B. Braun Overview
11.14.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 B. Braun Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 B. Braun Recent Developments
11.15 77 Elektronika
11.15.1 77 Elektronika Corporation Information
11.15.2 77 Elektronika Overview
11.15.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 77 Elektronika Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 77 Elektronika Recent Developments
11.16 AgaMatrix
11.16.1 AgaMatrix Corporation Information
11.16.2 AgaMatrix Overview
11.16.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 AgaMatrix Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 AgaMatrix Recent Developments
11.17 Terumo
11.17.1 Terumo Corporation Information
11.17.2 Terumo Overview
11.17.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Terumo Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Terumo Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Network Point-of-Care Glucose Testing Device Industry Chain Analysis
12.2 Network Point-of-Care Glucose Testing Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Network Point-of-Care Glucose Testing Device Production Mode & Process
12.4 Network Point-of-Care Glucose Testing Device Sales and Marketing
12.4.1 Network Point-of-Care Glucose Testing Device Sales Channels
12.4.2 Network Point-of-Care Glucose Testing Device Distributors
12.5 Network Point-of-Care Glucose Testing Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Network Point-of-Care Glucose Testing Device Industry Trends
13.2 Network Point-of-Care Glucose Testing Device Market Drivers
13.3 Network Point-of-Care Glucose Testing Device Market Challenges
13.4 Network Point-of-Care Glucose Testing Device Market Restraints
14 Key Findings in The Global Network Point-of-Care Glucose Testing Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Network Point-of-Care Glucose Testing Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.5uL/0.6uL
Table 3. Major Manufacturers of 1uL
Table 4. Major Manufacturers of 1.5uL
Table 5. Major Manufacturers of Others
Table 6. Global Network Point-of-Care Glucose Testing Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Network Point-of-Care Glucose Testing Device Sales by Region (2017-2022) & (K Units)
Table 9. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2017-2022)
Table 10. Global Network Point-of-Care Glucose Testing Device Sales by Region (2023-2028) & (K Units)
Table 11. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2023-2028)
Table 12. Global Network Point-of-Care Glucose Testing Device Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2017-2022)
Table 14. Global Network Point-of-Care Glucose Testing Device Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2023-2028)
Table 16. Global Network Point-of-Care Glucose Testing Device Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Network Point-of-Care Glucose Testing Device Sales Share by Manufacturers (2017-2022)
Table 18. Global Network Point-of-Care Glucose Testing Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Network Point-of-Care Glucose Testing Device Revenue Share by Manufacturers (2017-2022)
Table 20. Network Point-of-Care Glucose Testing Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Network Point-of-Care Glucose Testing Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Network Point-of-Care Glucose Testing Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Network Point-of-Care Glucose Testing Device as of 2021)
Table 23. Network Point-of-Care Glucose Testing Device Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Network Point-of-Care Glucose Testing Device Product Offered
Table 25. Date of Manufacturers Enter into Network Point-of-Care Glucose Testing Device Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Network Point-of-Care Glucose Testing Device Sales by Type (2017-2022) & (K Units)
Table 28. Global Network Point-of-Care Glucose Testing Device Sales by Type (2023-2028) & (K Units)
Table 29. Global Network Point-of-Care Glucose Testing Device Sales Share by Type (2017-2022)
Table 30. Global Network Point-of-Care Glucose Testing Device Sales Share by Type (2023-2028)
Table 31. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Network Point-of-Care Glucose Testing Device Revenue Share by Type (2017-2022)
Table 34. Global Network Point-of-Care Glucose Testing Device Revenue Share by Type (2023-2028)
Table 35. Network Point-of-Care Glucose Testing Device Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Network Point-of-Care Glucose Testing Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Network Point-of-Care Glucose Testing Device Sales by Application (2017-2022) & (K Units)
Table 38. Global Network Point-of-Care Glucose Testing Device Sales by Application (2023-2028) & (K Units)
Table 39. Global Network Point-of-Care Glucose Testing Device Sales Share by Application (2017-2022)
Table 40. Global Network Point-of-Care Glucose Testing Device Sales Share by Application (2023-2028)
Table 41. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Network Point-of-Care Glucose Testing Device Revenue Share by Application (2017-2022)
Table 44. Global Network Point-of-Care Glucose Testing Device Revenue Share by Application (2023-2028)
Table 45. Network Point-of-Care Glucose Testing Device Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Network Point-of-Care Glucose Testing Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Network Point-of-Care Glucose Testing Device Sales by Type (2017-2022) & (K Units)
Table 48. North America Network Point-of-Care Glucose Testing Device Sales by Type (2023-2028) & (K Units)
Table 49. North America Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Network Point-of-Care Glucose Testing Device Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Network Point-of-Care Glucose Testing Device Sales by Application (2017-2022) & (K Units)
Table 52. North America Network Point-of-Care Glucose Testing Device Sales by Application (2023-2028) & (K Units)
Table 53. North America Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Network Point-of-Care Glucose Testing Device Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Network Point-of-Care Glucose Testing Device Sales by Country (2017-2022) & (K Units)
Table 56. North America Network Point-of-Care Glucose Testing Device Sales by Country (2023-2028) & (K Units)
Table 57. North America Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Network Point-of-Care Glucose Testing Device Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Network Point-of-Care Glucose Testing Device Sales by Type (2017-2022) & (K Units)
Table 60. Europe Network Point-of-Care Glucose Testing Device Sales by Type (2023-2028) & (K Units)
Table 61. Europe Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Network Point-of-Care Glucose Testing Device Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Network Point-of-Care Glucose Testing Device Sales by Application (2017-2022) & (K Units)
Table 64. Europe Network Point-of-Care Glucose Testing Device Sales by Application (2023-2028) & (K Units)
Table 65. Europe Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Network Point-of-Care Glucose Testing Device Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Network Point-of-Care Glucose Testing Device Sales by Country (2017-2022) & (K Units)
Table 68. Europe Network Point-of-Care Glucose Testing Device Sales by Country (2023-2028) & (K Units)
Table 69. Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Network Point-of-Care Glucose Testing Device Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Network Point-of-Care Glucose Testing Device Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Network Point-of-Care Glucose Testing Device Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Network Point-of-Care Glucose Testing Device Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Network Point-of-Care Glucose Testing Device Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Network Point-of-Care Glucose Testing Device Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Network Point-of-Care Glucose Testing Device Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Network Point-of-Care Glucose Testing Device Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Network Point-of-Care Glucose Testing Device Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2023-2028) & (US$ Million)
Table 107. Roche Holding AG Corporation Information
Table 108. Roche Holding AG Description and Major Businesses
Table 109. Roche Holding AG Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Roche Holding AG Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Roche Holding AG Recent Developments
Table 112. Ascensia Diabetes Care Holdings AG Corporation Information
Table 113. Ascensia Diabetes Care Holdings AG Description and Major Businesses
Table 114. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Ascensia Diabetes Care Holdings AG Recent Developments
Table 117. Nova Biomedical Corporation Information
Table 118. Nova Biomedical Description and Major Businesses
Table 119. Nova Biomedical Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Nova Biomedical Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Nova Biomedical Recent Developments
Table 122. LifeScan, Inc. Corporation Information
Table 123. LifeScan, Inc. Description and Major Businesses
Table 124. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. LifeScan, Inc. Recent Developments
Table 127. Danaher Corporation Corporation Information
Table 128. Danaher Corporation Description and Major Businesses
Table 129. Danaher Corporation Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Danaher Corporation Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Danaher Corporation Recent Developments
Table 132. Prodigy Diabetes Care Corporation Information
Table 133. Prodigy Diabetes Care Description and Major Businesses
Table 134. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Prodigy Diabetes Care Recent Developments
Table 137. Johnson & Johnson Corporation Information
Table 138. Johnson & Johnson Description and Major Businesses
Table 139. Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Johnson & Johnson Recent Developments
Table 142. Nipro Corporation Information
Table 143. Nipro Description and Major Businesses
Table 144. Nipro Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Nipro Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Nipro Recent Developments
Table 147. ACON Laboratories, Inc. Corporation Information
Table 148. ACON Laboratories, Inc. Description and Major Businesses
Table 149. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. ACON Laboratories, Inc. Recent Developments
Table 152. Trividia Health, Inc. Corporation Information
Table 153. Trividia Health, Inc. Description and Major Businesses
Table 154. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Trividia Health, Inc. Recent Developments
Table 157. Panasonic Healthcare Holdings Corporation Information
Table 158. Panasonic Healthcare Holdings Description and Major Businesses
Table 159. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Panasonic Healthcare Holdings Recent Developments
Table 162. EKF Diagnostics Corporation Information
Table 163. EKF Diagnostics Description and Major Businesses
Table 164. EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. EKF Diagnostics Recent Developments
Table 167. Omron Corporation Information
Table 168. Omron Description and Major Businesses
Table 169. Omron Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Omron Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Omron Recent Developments
Table 172. B. Braun Corporation Information
Table 173. B. Braun Description and Major Businesses
Table 174. B. Braun Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. B. Braun Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. B. Braun Recent Developments
Table 177. 77 Elektronika Corporation Information
Table 178. 77 Elektronika Description and Major Businesses
Table 179. 77 Elektronika Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. 77 Elektronika Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. 77 Elektronika Recent Developments
Table 182. AgaMatrix Corporation Information
Table 183. AgaMatrix Description and Major Businesses
Table 184. AgaMatrix Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. AgaMatrix Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. AgaMatrix Recent Developments
Table 187. Terumo Corporation Information
Table 188. Terumo Description and Major Businesses
Table 189. Terumo Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. Terumo Network Point-of-Care Glucose Testing Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Terumo Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Network Point-of-Care Glucose Testing Device Distributors List
Table 195. Network Point-of-Care Glucose Testing Device Customers List
Table 196. Network Point-of-Care Glucose Testing Device Market Trends
Table 197. Network Point-of-Care Glucose Testing Device Market Drivers
Table 198. Network Point-of-Care Glucose Testing Device Market Challenges
Table 199. Network Point-of-Care Glucose Testing Device Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Network Point-of-Care Glucose Testing Device Product Picture
Figure 3. Global Network Point-of-Care Glucose Testing Device Market Share by Type in 2021 & 2028
Figure 3. 0.5uL/0.6uL Product Picture
Figure 4. 1uL Product Picture
Figure 5. 1.5uL Product Picture
Figure 6. Others Product Picture
Figure 7. Global Network Point-of-Care Glucose Testing Device Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Household
Figure 11. Network Point-of-Care Glucose Testing Device Report Years Considered
Figure 12. Global Network Point-of-Care Glucose Testing Device Sales 2017-2028 (K Units)
Figure 13. Global Network Point-of-Care Glucose Testing Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Network Point-of-Care Glucose Testing Device Revenue 2017-2028 (US$ Million)
Figure 15. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2017-2022)
Figure 17. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2023-2028)
Figure 18. North America Network Point-of-Care Glucose Testing Device Sales YoY (2017-2028) & (K Units)
Figure 19. North America Network Point-of-Care Glucose Testing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Network Point-of-Care Glucose Testing Device Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Network Point-of-Care Glucose Testing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Network Point-of-Care Glucose Testing Device Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Network Point-of-Care Glucose Testing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Network Point-of-Care Glucose Testing Device Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Network Point-of-Care Glucose Testing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Network Point-of-Care Glucose Testing Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Network Point-of-Care Glucose Testing Device in the World: Market Share by Network Point-of-Care Glucose Testing Device Revenue in 2021
Figure 30. Global Network Point-of-Care Glucose Testing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2017-2028)
Figure 32. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2017-2028)
Figure 33. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2017-2028)
Figure 34. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2017-2028)
Figure 35. North America Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2017-2028)
Figure 36. North America Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2017-2028)
Figure 37. North America Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2017-2028)
Figure 38. North America Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2017-2028)
Figure 39. North America Network Point-of-Care Glucose Testing Device Sales Share by Country (2017-2028)
Figure 40. North America Network Point-of-Care Glucose Testing Device Revenue Share by Country (2017-2028)
Figure 41. United States Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2017-2028)
Figure 44. Europe Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2017-2028)
Figure 45. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2017-2028)
Figure 46. Europe Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2017-2028)
Figure 47. Europe Network Point-of-Care Glucose Testing Device Sales Share by Country (2017-2028)
Figure 48. Europe Network Point-of-Care Glucose Testing Device Revenue Share by Country (2017-2028)
Figure 49. Germany Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 50. France Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Network Point-of-Care Glucose Testing Device Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Network Point-of-Care Glucose Testing Device Revenue Share by Region (2017-2028)
Figure 60. China Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 63. India Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2017-2028)
Figure 70. Latin America Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2017-2028)
Figure 72. Latin America Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Network Point-of-Care Glucose Testing Device Sales Share by Country (2017-2028)
Figure 74. Latin America Network Point-of-Care Glucose Testing Device Revenue Share by Country (2017-2028)
Figure 75. Mexico Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Network Point-of-Care Glucose Testing Device Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue Share by Country (2017-2028)
Figure 84. Turkey Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Network Point-of-Care Glucose Testing Device Revenue (2017-2028) & (US$ Million)
Figure 87. Network Point-of-Care Glucose Testing Device Value Chain
Figure 88. Network Point-of-Care Glucose Testing Device Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed